Alkeon Capital Management - CARIBOU BIOSCIENCES INC ownership

CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 128 filers reported holding CARIBOU BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.

Quarter-by-quarter ownership
Alkeon Capital Management ownership history of CARIBOU BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$7,862,445
+36.3%
1,644,863
+21.2%
0.01%
+40.0%
Q2 2023$5,767,518
+3.0%
1,357,063
+28.7%
0.01%
-16.7%
Q1 2023$5,600,164
-15.8%
1,054,645
-0.4%
0.01%
-53.8%
Q4 2022$6,648,027
-48.4%
1,058,603
-13.4%
0.03%
-38.1%
Q3 2022$12,893,000
+171.8%
1,222,091
+39.9%
0.04%
+223.1%
Q2 2022$4,744,000
-57.8%
873,549
-28.6%
0.01%
-43.5%
Q1 2022$11,233,000
-40.3%
1,223,549
-1.9%
0.02%
-34.3%
Q4 2021$18,812,000
-36.8%
1,246,6250.0%0.04%
-30.0%
Q3 2021$29,757,0001,246,6250.05%
Other shareholders
CARIBOU BIOSCIENCES INC shareholders Q3 2023
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 674,196$10,174,0006.39%
72 Investment Holdings, LLC 474,067$7,154,0006.35%
Velan Capital Investment Management LP 210,695$3,179,0002.47%
PFM Health Sciences, LP 4,092,309$59,418,0002.02%
Monashee Investment Management LLC 504,377$7,611,0001.88%
CloudAlpha Capital Management Limited/Hong Kong 415,000$6,262,0001.49%
Avidity Partners Management LP 2,674,067$40,352,0000.86%
Rokos Capital Management LLP 570,359$8,604,0000.52%
Green Alpha Advisors, LLC 35,592$537,0000.36%
Tekla Capital Management LLC 699,377$9,875,0000.32%
View complete list of CARIBOU BIOSCIENCES INC shareholders